exosomal mirna microarray analysis (CapitalBio Corporation)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

CapitalBio Corporation exosomal mirna microarray analysis

NK-derived exosomes from lean mice attenuate obesity-induced insulin resistance. a Fasting blood glucose of NCD and HFD mice after group feeding. b – d OGTT ( b ), ITT ( c ), and HOMA-IR index ( d ) of HFD mice and NCD mice ( n = 48) were recorded at 42 days after group feeding. HOMA-IR = Fasting blood glucose value × fasting serum insulin value/22.5. e Transmission electron micrographs of NK-derived exosomes. Scale bar, 100 nm. f NanoSight particle tracking analysis showing the particle size of NK-derived exosomes isolated from NCD and HFD mice. g Western blot assays of <t>exosomal</t> markers TSG101, HSP70, CD63, and CD9. h – k After blank liposomes, NCD-Exos, and HFD-Exos were separately injected into NCD or HFD mice via tail vein, fasting blood glucose ( h ), OGTT ( i ), ITT ( j ), and HOMA-IR ( k ) were assessed in each group. G1: HFD mice treated with blank liposomes ( n = 3); G2: HFD mice treated with HFD-Exos ( n = 3); G3: HFD mice treated with NCD-Exos ( n = 3); G4: NCD mice treated with blank liposomes ( n = 3); G5: NCD mice treated with HFD-Exos ( n = 3); and G6: NCD mice treated with NCD-Exos ( n = 3). l After NCD-Exos labeled with PKH26 were transferred into recipient mice, fluorescence images of the liver, islets, SATs, VATs, and skeletal muscles were observed by in vitro imaging system. Scale bar, 5 mm. m The weight of VATs from HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. n Liver triglyceride content of HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. o , p ELISA assays of IL-6, IL-1β, and TNF-α expression in VATs and livers of HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t-test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Exosomal Mirna Microarray Analysis, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+data+analysis/exosomal+mirna+microarray+analysis/pmc08632983-228-0-7
Average 90 stars, based on 1 article reviews

exosomal mirna microarray analysis - by Bioz Stars, 2026-09

90/100 stars

Images

1) Product Images from "Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes"

Article Title: Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes

Journal: Signal Transduction and Targeted Therapy

doi: 10.1038/s41392-021-00805-y

Figure Legend Snippet: NK-derived exosomes from lean mice attenuate obesity-induced insulin resistance. a Fasting blood glucose of NCD and HFD mice after group feeding. b – d OGTT ( b ), ITT ( c ), and HOMA-IR index ( d ) of HFD mice and NCD mice ( n = 48) were recorded at 42 days after group feeding. HOMA-IR = Fasting blood glucose value × fasting serum insulin value/22.5. e Transmission electron micrographs of NK-derived exosomes. Scale bar, 100 nm. f NanoSight particle tracking analysis showing the particle size of NK-derived exosomes isolated from NCD and HFD mice. g Western blot assays of exosomal markers TSG101, HSP70, CD63, and CD9. h – k After blank liposomes, NCD-Exos, and HFD-Exos were separately injected into NCD or HFD mice via tail vein, fasting blood glucose ( h ), OGTT ( i ), ITT ( j ), and HOMA-IR ( k ) were assessed in each group. G1: HFD mice treated with blank liposomes ( n = 3); G2: HFD mice treated with HFD-Exos ( n = 3); G3: HFD mice treated with NCD-Exos ( n = 3); G4: NCD mice treated with blank liposomes ( n = 3); G5: NCD mice treated with HFD-Exos ( n = 3); and G6: NCD mice treated with NCD-Exos ( n = 3). l After NCD-Exos labeled with PKH26 were transferred into recipient mice, fluorescence images of the liver, islets, SATs, VATs, and skeletal muscles were observed by in vitro imaging system. Scale bar, 5 mm. m The weight of VATs from HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. n Liver triglyceride content of HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. o , p ELISA assays of IL-6, IL-1β, and TNF-α expression in VATs and livers of HFD mice treated with NCD-Exos, HFD-Exos, or blank liposomes. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t-test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Techniques Used: Derivative Assay, Transmission Assay, Isolation, Western Blot, Liposomes, Injection, Labeling, Fluorescence, Muscles, In Vitro, Imaging, Enzyme-linked Immunosorbent Assay, Expressing

NK-derived exosomal miR-1249-3p mediates cellular insulin sensitivity and inflammation. a Microarray analysis of significantly expressed exosomal miRNAs between NCD-Exos and HFD-Exos was presented in a heatmap. b qRT-PCR assay of miR-1249-3p expression in splenic NK cells, NK-derived exosomes, and circulating exosomes from NCD or HFD mice. c NK cells transfected with a Cy3-labeled miR-1249-3p mimic were co-cultured with 3T3-L1 adipocytes or AML12 cells in a Transwell TM plate (membrane pore = 0.4 mm) plate. Scale bar, 100 μm. d – g After transfecting with miR-1249-3p mimic, miR-NC, inhibitor, and inh-NC, the glucose uptake content of 3T3-L1 adipocytes ( d ) and glucose production content of AML12 cells ( f ) were measured, and the concentrations of IL-6, TNF-α, and IL-1β secreted by 3T3-L1 adipocytes ( e ) and AML12 cells ( g ) were detected by ELISA. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Figure Legend Snippet: NK-derived exosomal miR-1249-3p mediates cellular insulin sensitivity and inflammation. a Microarray analysis of significantly expressed exosomal miRNAs between NCD-Exos and HFD-Exos was presented in a heatmap. b qRT-PCR assay of miR-1249-3p expression in splenic NK cells, NK-derived exosomes, and circulating exosomes from NCD or HFD mice. c NK cells transfected with a Cy3-labeled miR-1249-3p mimic were co-cultured with 3T3-L1 adipocytes or AML12 cells in a Transwell TM plate (membrane pore = 0.4 mm) plate. Scale bar, 100 μm. d – g After transfecting with miR-1249-3p mimic, miR-NC, inhibitor, and inh-NC, the glucose uptake content of 3T3-L1 adipocytes ( d ) and glucose production content of AML12 cells ( f ) were measured, and the concentrations of IL-6, TNF-α, and IL-1β secreted by 3T3-L1 adipocytes ( e ) and AML12 cells ( g ) were detected by ELISA. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Techniques Used: Derivative Assay, Microarray, Quantitative RT-PCR, Expressing, Transfection, Labeling, Cell Culture, Membrane, Enzyme-linked Immunosorbent Assay

Exosomal miR-1249-3p directly targets SKOR1 to mediate insulin sensitivity. a The potential targets of miR-1249-3p were predicted by integrating the results of two databases (TargetScan and miRDB). b Western blot analysis of SKOR1 in 3T3-L1 adipocytes and AML12 cells with the indicated treatments. c The wild-type and a mutated type of binding site between miR-1249-3p and SKOR1. d Relative luciferase activity of AML12 cells in the presence of indicated treatments. e Western blot analysis of SKOR1 expression in the VATs and livers of HFD mice after NCD-Exos or HFD-Exos treatment. f – i The effect of sh-SKOR1 on glucose uptake capacity in 3T3-L1 adipocytes ( f ), glucose production capacity in AML12 cells ( g ), and expression levels of IL-6, TNF-α, and IL-1β ( h , i ). j – q Glucose uptake content of 3T3-L1 adipocytes ( j ) and glucose production content of AML12 cells ( n ) with the indicated treatments were measured, as well as the expression levels of IL-6, TNF-α, and IL-1β ( k – m and o – q ). Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Figure Legend Snippet: Exosomal miR-1249-3p directly targets SKOR1 to mediate insulin sensitivity. a The potential targets of miR-1249-3p were predicted by integrating the results of two databases (TargetScan and miRDB). b Western blot analysis of SKOR1 in 3T3-L1 adipocytes and AML12 cells with the indicated treatments. c The wild-type and a mutated type of binding site between miR-1249-3p and SKOR1. d Relative luciferase activity of AML12 cells in the presence of indicated treatments. e Western blot analysis of SKOR1 expression in the VATs and livers of HFD mice after NCD-Exos or HFD-Exos treatment. f – i The effect of sh-SKOR1 on glucose uptake capacity in 3T3-L1 adipocytes ( f ), glucose production capacity in AML12 cells ( g ), and expression levels of IL-6, TNF-α, and IL-1β ( h , i ). j – q Glucose uptake content of 3T3-L1 adipocytes ( j ) and glucose production content of AML12 cells ( n ) with the indicated treatments were measured, as well as the expression levels of IL-6, TNF-α, and IL-1β ( k – m and o – q ). Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Techniques Used: Western Blot, Binding Assay, Luciferase, Activity Assay, Expressing

MiR-1249-3p relieves insulin resistance and inflammation via the SKOR1-SMAD6-TLR4-NF-κB axis. a – c After transfection with a miR-1249-3p mimic, miR-NC, or specific siRNA to SKOR1 or SMAD6, qRT-PCR analysis of miR-1249-3p ( a ), SKOR1 ( b ) and SMAD6 ( c ) expression in 3T3-L1 adipocytes cells with the indicated treatments was performed. d , g The expression of p-p65 and p65 in 3T3-L1 adipocytes cells with the indicated treatments was performed by western blot. e , f , h IL-1β, IL-6, and TNF-α expression in 3T3-L1 adipocytes cells subjected to the indicated treatments was assessed by ELISA. i The signaling pathway through which NK-derived exosomal miR-1249-3p regulates insulin resistance in type 2 diabetes mice. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Figure Legend Snippet: MiR-1249-3p relieves insulin resistance and inflammation via the SKOR1-SMAD6-TLR4-NF-κB axis. a – c After transfection with a miR-1249-3p mimic, miR-NC, or specific siRNA to SKOR1 or SMAD6, qRT-PCR analysis of miR-1249-3p ( a ), SKOR1 ( b ) and SMAD6 ( c ) expression in 3T3-L1 adipocytes cells with the indicated treatments was performed. d , g The expression of p-p65 and p65 in 3T3-L1 adipocytes cells with the indicated treatments was performed by western blot. e , f , h IL-1β, IL-6, and TNF-α expression in 3T3-L1 adipocytes cells subjected to the indicated treatments was assessed by ELISA. i The signaling pathway through which NK-derived exosomal miR-1249-3p regulates insulin resistance in type 2 diabetes mice. Experiments were performed at least in triplicate, and the results are shown as the mean ± s.d. Student’s t -test was used to analyze the data. (* P < 0.05; ** P < 0.01; *** P < 0.001)

Techniques Used: Transfection, Quantitative RT-PCR, Expressing, Western Blot, Enzyme-linked Immunosorbent Assay, Derivative Assay

Microarray:

Article Title: Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes
Article Snippet: After 12 h serum starvation, AML12 cells were stimulated with 10 nM insulin at 37 °C for 24 h with glucose production buffer (no phenol red, glucose-free DMEM medium containing 20 mM l -sodium lactate, 2 mM sodium pyruvate, 2 mM l -glutamine, and 15 mM N-2-hydroxyethylpiperazine-N-ethane-sulphonicacid) (Sangon biotech, Shanghai, China), and then the cell culture supernatant was collected for determination of glucose content using a glucose detection kit. .. Exosomal miRNA microarray analysis was performed at CapitalBio Technology, Inc. (Beijing, China) using Agilent Mouse miRNA 8 × 60K V21.0 Microarray (Agilent Technologies, California, USA). .. Quantile normalization and subsequent data processing were performed using Quantile algorithm, GeneSpringGX Software (Agilent Technologies, California, USA).

Review

exosomal mirna microarray analysis (CapitalBio Corporation)

Structured Review

Images

1) Product Images from "Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes"

Related Articles

Microarray:

Similar Products

Image Search Results